Cellworks Singula™ Accurately Predicts Clinical Outcome from Treatments in Patients with NSCLC SOUTH SAN FRANCISCO, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a world leader in Personalized Medicine in the key therapeutic areas of Oncology and Immunology, today announced...